注册 | 登录
点击这里给我发消息
所有产品
  • 所有产品
  • 一抗
  • 裂解液
>   首页   >   产品   >   一抗   >   其他   >   Anti-JAG1 / CD339 Reference Antibody (Genentech patent anti-Jagged1)   

Anti-JAG1 / CD339 Reference Antibody (Genentech patent anti-Jagged1)

     
  • 0 - Anti-JAG1 / CD339 Reference Antibody (Genentech patent anti-Jagged1) APR11511
    Anti-JAG1 / CD339 Reference Antibody (Genentech patent anti-Jagged1) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
  • 0 - Anti-JAG1 / CD339 Reference Antibody (Genentech patent anti-Jagged1) APR11511
    The purity of Anti-JAG1 / CD339 Reference Antibody (Genentech patent anti-Jagged1) is 98.5%, determined by SEC-HPLC.
  • 0 - Anti-JAG1 / CD339 Reference Antibody (Genentech patent anti-Jagged1) APR11511
    Immobilized hu-Jagged1-his, It’s target at 2 µg/mL can bind bamlanivimab, EC50= 0.01259 µg/mL.
  • 产品详情
  • 实验流程
Product Information
Application
  • Applications Legend:
  • E=ELISA
  • WB=Western Blotting
  • IHC=Immunohistochemistry
  • IHC-P=Immunohistochemistry (Paraffin)
  • IP=Immunoprecipitation
  • IF=Immunofluorescence
  • IC=Immunochemistry
  • ICC=Immunocytochemistry
  • FC=Flow Cytometry
  • DB=Dot Blot
Functional assay, Kinetics (SPR), Kinetics (BLI), FACS, E, FTA
Primary Accession P78504
Reactivity Human
Clonality Monoclonal
Isotype IgG1
Calculated MW 133799 Da
Additional Information
Target/Specificity JAG1 / CD339
Expression system CHO

For Research Use Only. Not For Use In Diagnostic Procedures.

Patent Notice: The variable region sequence of this antibody is derived from a published third-party patent. This product is manufactured independently as a Research Use Only (RUO) reagent and is not licensed, sponsored, or endorsed by the patent holder. It is intended solely for research purposes. Customers considering any commercial, diagnostic, or therapeutic use should independently evaluate freedom-to-operate with respect to relevant third-party patents.

Protein Information
Name JAG1
Synonyms JAGL1
Function Ligand for multiple Notch receptors and involved in the mediation of Notch signaling (PubMed:18660822, PubMed:20437614). May be involved in cell-fate decisions during hematopoiesis (PubMed:9462510). Seems to be involved in early and late stages of mammalian cardiovascular development. Inhibits myoblast differentiation (By similarity). Enhances fibroblast growth factor-induced angiogenesis (in vitro).
Cellular Location Membrane; Single-pass type I membrane protein. Cell membrane
Tissue Location Widely expressed in adult and fetal tissues. In cervix epithelium expressed in undifferentiated subcolumnar reserve cells and squamous metaplasia. Expression is up-regulated in cervical squamous cell carcinoma. Expressed in bone marrow cell line HS-27a which supports the long-term maintenance of immature progenitor cells
Research Areas
FeedBack

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。

如有疑问,联系:0512-88856768 tech-china@abcepta.com.


我要评价